Dysport

Galderma’s Dysport, approved in 2009, is known for its ability to spread a bit more upon injection, which makes it perfect for treating larger areas where a more subtle diffusion is desired. Like Xeomin, it does not contain accessory proteins and starts to show results within a week. The effects of Dysport are similar in duration to its competitors, lasting about three months. This product is ideal for clients seeking a natural look, especially across extensive areas of the face.